Initial IM Morphine Dosing for Acute Pain Management
Recommended Starting Dose
- The initial IM dose should be 2-5 mg for opioid-naive patients, with the specific dose within this range determined by pain severity, age, and frailty status 1, 2
- For moderate-to-severe pain requiring aggressive initial management, use 5 mg IM as the starting dose 1
- For elderly patients (>70 years), frail patients, or those with smaller body habitus, start at the lower end (2 mg IM) to account for decreased clearance and increased opioid sensitivity 1, 2
Titration Protocol
- Reassess pain intensity every 15 minutes after the initial dose using a numerical rating scale 1, 2
- If pain persists or remains severe, administer additional 2 mg IM boluses every 15 minutes as needed 1, 2
- If pain control is inadequate after the initial dose, increase subsequent doses by 50-100% of the previous dose, prioritizing rapid dose escalation over conservative dosing 1, 2
- There is no dose ceiling when titrating to symptoms during acute pain management 1, 2
Important Caveats and Pitfalls
- Never start with doses ≥20 mg in opioid-naive patients, as this significantly increases adverse effects without proportional analgesic benefit 1, 2
- IM morphine should not be used as first-line if IV access is available, since IV administration allows for more precise titration with faster onset 3, 2
- The guideline consensus strongly recommends subcutaneous administration over IM for chronic cancer pain because it is simpler and less painful, though for acute dosing in this scenario IM is acceptable 3
Monitoring Requirements
- Monitor respiratory rate, sedation level, and vital signs every 15-30 minutes during initial titration 1
- Document the specific rationale for each dose administered (e.g., "for severe pain rated 8/10") 1, 2
Concurrent Management
- Initiate a bowel regimen simultaneously with stimulant laxatives (senna) and stool softeners, as constipation is the primary persistent side effect of opioids 4, 5, 1, 2
- Order antiemetics pro re nata to manage opioid-induced nausea, which occurs in up to two-thirds of patients initially but typically resolves within days 3, 1, 2